Announcements Trials
Browse Landscape

Phase

Phase NA 25Phase 2 11Phase 2/3 2Phase 1/2 2Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 630Triple Negative Breast Neoplasms 166Ovarian Neoplasms 103Carcinoma, Non-Small-Cell Lung 100Neoplasm Metastasis 76Colorectal Neoplasms 64Melanoma 61Stomach Neoplasms 60Neoplasms 56Pancreatic Neoplasms 55Squamous Cell Carcinoma of Head and Neck 50Prostatic Neoplasms 48Endometrial Neoplasms 48Lung Neoplasms 47Uterine Cervical Neoplasms 36Carcinoma, Renal Cell 35Sarcoma 33Head and Neck Neoplasms 33Esophageal Neoplasms 32Breast Neoplasms, Male 29Urinary Bladder Neoplasms 26Small Cell Lung Carcinoma 26Colonic Neoplasms 26Carcinoma, Transitional Cell 23Carcinoma, Ovarian Epithelial 21Lymphoma 18Brain Neoplasms 18Kidney Neoplasms 17Carcinoma, Hepatocellular 17Liver Neoplasms 15

Interventions

Thioctic Acid 1Cilostazol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Peripheral Nervous System Diseases × Breast × Clear all
NCT05298696 2023-03-15

Efficacy of Cilostazol in Prevention of Peripheral Neuropathy

Mansoura University

Phase 1/2 Completed
71 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT01313117 2014-10-02

Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy

Northwestern University

Phase 1/2 Completed
9 enrolled 7 charts
Breast

Breast Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡